Kanwal Raghav, MD, MBBS: For HER2 testing, as far as metastatic colorectal ... We’re routinely using next-generation sequencing [NGS] in all patients with metastatic colorectal cancer.

In their analysis, the researchers looked at close to 30,000 cancer-related NGS claims filed by almost 25,000 unique Medicare beneficiaries, culled from a 20% random sample of Medicare recipients ...

“The CAP was the first accrediting organization in the U.S. to publish accreditation requirements specific to NGS to address its emerging use in diagnostic testing,” explained CAP President Emily ...

In this webinar, discover how trusted data curated by highly experienced variant experts can elevate your lab’s clinical NGS testing pipeline. Get acquainted with COSMIC (Catalogue Of Somatic ...

OneOncology Presents Abstracts at ASCO Highlighting Importance of Increasing NGS Testing Thomas Stricker, MD, Ph.D., Medical Director of Precision Medicine for OneOncology, is the first author of ...

A total of 4,415 patients were identified, for whom actionable molecular abnormalities (EGFR, ALK, ROS1, BRAF, MET, RET, HER2, NTRK) were identified through tissue-based or blood-based NGS or ...

Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare ...

The DNA-based NF1/SPRED1-only by NGS involves sequencing as well as deletion/duplication analysis of the entire coding NF1/SPRED1 regions plus the alternatively spliced NF1 exons 9br, 23a and 48a (67 ...

Investigators note that although the overall cost for implementing next-generation sequencing (NGS) testing would be more than implementing current polymerase chain reaction (PCR)–based testing ...

WAYNE, Pa. & PARIS--(BUSINESS WIRE)--PathoQuest, a leader in the development and provision of Next Generation Sequencing (NGS) testing services for the biopharmaceutical industry, today announced ...